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Summary.-Eleven human bladder carcinomata of different degrees of differentia-
tion were implanted in mice immunosuppressed by thymectomy, anti-thymocyte
serum and x-rays. Seven carcinomata grew well and one poorly and 3 produced
mainly fibrous nodules in the mice. Normal human bladder tissues were grown
from 4 other patients. The administration of a haematoporphyrin derivative
(HpD), followed 24 h later by exposure to white light, caused marked destruction
of tumours but little or none of normal bladder tissues. HpD or light alone caused
no damage to tumours or normal tissues.
It is suggested that photodynamic therapy may be applicable in the treatment
of superficial transitional cell carcinoma of the bladder.
PORPHYRINS are powerful photody-
namic agents which can sensitize tissues
to light (Blum, 1964; Diamond et al.,
1972). Animal tumours take up and
retain porphyrins selectively (Auler and
Banzer, 1942; Figge, Weiland and Man-
ganiello, 1948), and clinical studies have
shown that this also occurs in patients
with a variety of epithelial tumours
(Gray et al., 1967; Lipson, Baldes and
Olsen, 1964; Gregoire et al., 1968; Leonard
and Beck, 1971; Kyriazis, Balin and
Lipson, 1973). It has often been sug-
gested that the photosensitizing action of
porphyrins might be used therapeutically,
but it was not until recently that the
destruction of an animal tumour (a rat
glioma) with haematoporphyrin and light
was reported (Diamond et al., 1972).
Most tumours do not lend themselves
to phototherapy because they are deeply
situated. However, with modern light
sources and light transmission systems,
phototherapy might be used for accessible
tumours such as carcinoma ofthe bladder.
There have been no previous reports
regarding the localization of porphyrins
in carcinoma of the bladder, or on the
differential destruction of normal and
malignant tissues using light and por-
phyrins. This study was therefore made
to discover whether a derivative of
haematoporphyrin (hereafter called HpD)
(Lipson et al., 1961) is selectively taken
up by human transitional cell carcinoma
of the bladder growing in immunosup-
pressed mice (Berenbaum et al., 1974),
and whether such carcinomata cani be
destroyed by a combined treatment with
light and HpD which does not affect
normal bladder tissues. HpD was used
because, of the porphyrins tested to date,
it is the best localized and visualized by
its fluorescence in malignant tumours
(Lipson et al., 1961; Barker, Henderson
and Storey, 1970).
MATERIALS AND METHODS
Male and female CBA mice were thym-
ectomized when 5-9 weeks old; 7 days later
they received the first of 4 doses of 0-5 ml
ofrabbit anti-mouse thymocyte serum (ATS)
given on alternate days; ATS was prepared
according to the method of Levey and
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TABLE I. Details of Implanted Tissues
Tumours an(l
normal tissue Source of tissues
A 13iopsy
B Biopsy passaged into 2nd group
of mice at 30 days
C Transurethral resection
D Biopsy
E Transurethral resection
F Biopsy
G Transurethral resection
H Transurethral resection
J Partial cystectomy
K Total cystectomy after irradiation
L Biopsy
M Bladder diverticulectomy
N Biopsy of bladder
0 Prostatectomy, bladder neck
P Total cystectomy after irradiation
Medawar (1966). The mice were then given
300 rad whole body radiation in a Stabilipan
x-ray machine (225 kV, 27 rad/min, 1 mm Cu
filter). Implants oftumour and other tissues
were made wNithin 2 weeks of irradiation and
the mice were subsequently treated with
0 25 ml of ATS on Mondays, Wednesdays
and Fridays until they were sacrificed.
Bladder carcinomata from 11 patients
and normal bladder mucosa and muscle
from 4 patients were placed in Eagle's
minimal essential medium with added genta-
micin (20 mg/i) and kept at 4°C until
implanted (generally within 3 h). The
source and histological grade (Dukes, 1959)
of the tissues are given in Table 1. The
tissues were finely minced writh scissors and
0-2 ml of mince or 5-10 mm3 of more solid
material were injected subcutaneously into
both flanks of each mouse of a group which
varied in size depending on the amount of
tissue available.
The mice were used for experiments 9-30
days after implantation, when the nodules
appeared to be increasing in size. It was
not possible at the time of treatment to
distinguish nodules containing tumour from
those containing fibrous tissue only (Beren-
baum et al., 1974), except in those mice with
implants older than 30 days, when the
increase in size was obvious.
The HpD was prepared according to
a method previously described (Lipson et
al., 1961). Commercial haematoporphyrin
hydrochloride (Koch-Light) was dissolved
in 500 (v/v) sulphuric acid in glacial acetic
acid. After 30 min at room temperature
Hi;stological gra(le
Solid undifferentiated
Solid undlifferentiated
Papillary dlifferentiate(l
Solid undifferentiated
Solid differentiated
Solid undifferentiated
Papillary differentiated
Papillary (lifferentiate(l
Solid undifferentiated
Solid undifferentiated
Solid undifferentiatedl
Normal bladder tissue
Normal bladdler tissue
Normal bladder tissue
Normal bladder tissue
Growsth
+I
-+
t-
-P+
+
Days from
implantation
to sacrifice
16
33
13
15
26
22
25
13
21
20
18
12
21
13
16
it wAas filtered and 3 0 sodium acetate in
distilled water added to the solution until
a precipitate formed at approximately pH 5.
This Mwas then filtered off, washed thoroughly
with sterile pyrogen-free distilled wrater and
dried at room temperature in the dark.
This crystalline derivative (HpD) was then
dissolved in 04 N sodium hydroxide and the
pH adjusted to 7-4 with hydrochloric acid.
Solutions containing 1 mg/ml were sterilized
by Millipore filtration and stored in ampoules
at 4°C. A single batch was prepared and
used in all these experiments as it has been
shown that different batches vary widely
in their localizing ability (Gray et al., 1967).
A standard dose of 0-2 mg HpD per
mouse was injected intraperitoneally 24 h
before exposure of the nodules to light, the
abdomen having been shaved before the
injection.
The light source was a 400 watt Compact-
Source Iodide light (Thorn Lighting). The
beam was directed upwards with a 450
mirror through a 4 cm diameter perspex
rod 1 m long and then through a heat filter
(a 2 cm layer of 500 copper sulphate). It
delivered approximately 20,000 foot candles
of light 10 cm from the distal end of the rod.
The mice were anaesthetized with Avertin
(bromethol) and placed in a metal receptable
with a 1 cm2 aperture in which the nodule
wzas centred. All right-sided nodules were
exposed to the light through the aperture
for 30 min and the left-sided nodules used as
unexposed controls. Measurement by im-
planted thermocouples in a group of 10 mice
showed that exposure to light raised the
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subcutaneous temperature to a mean of
37 7°C (range 370-390) in the irradiated
area. There was no difference in tem-
perature rise between mice treated with
HpD and controls.
The mice were killed 48 h after exposure
to light and the nodules fixed in formalin.
Sections stained with haematoxylin and
eosin were coded and randomized, then
examined by one of us without knowledge
of the treatment given.
Nodules were classified as consisting of:
(1) tumour, (2) normal epithelium, (3) normal
muscle, (4) both normal epithelium and
muscle, (5) fibrous tissue only, (6) unidenti-
fiable recentlv necrotic tissue.
In order to follow the distribution of
HpD, tumour-bearing mice were killed 24 h
after receiving HpD and their organs, and
frozen sections of their tumours, examined
in u.v. light, using a Reichert Zetopan
microscope fitted with an HB200 mercury
vapour lamp, 3 mm BG12 and 2 mm BG38
primary filters and 1-5 mm OGI and 1 mm
GG9 secondary filters.
RESULTS
Growth of implants (Fig. 1)
Seven of the 11 carcinomata grew
well (A-G); most of the implanted
nodules contained solid areas of tumour
similar in structure to the original tumour
and with frequent mitoses (Fig. 2a).
One grew poorly (H), producing only
small amounts of tumour without evident
mitoses around the periphery of the dead
tissue from the original implant, but
tumour was present in all nodules.
With 3 groups (J, K, L), tumour was
found only in small amounts in 7 of 56
nodules and no mitoses were seen. Most
nodules consisted of fibrous tissue and,
in the case of group L, smooth muscle.
Fi(. I. Histological findings iii implant
nodules. Eaclh pair of s-mbols arranige(d
horizontally represents the 2 nioclules in a
single mlloutlse, one expose(i to light ain(d the
othti shielded. 0 tumour; A fibrouis
tissute oiil- a iirm0lnal epithelium; I
siO( o)tli mu1lscle; uni(lentifiable recently
iwe(lotic tissue; 100o iocltule foull(l.
The extent of (lamage i.s indicated thtus:
O t-otal, X sub-total, * superficial.
to i re5gulol,. slight, O nolie.
* '1\ouse p)robably did niot receive HtpD ip.p.
(sce text).
Li
239
_ +J. F. KELLY, M. E. SNELL AND M. C. BERENBAUM 240
:>
0 n
0D
3 e
4._
4a;
0 o~
(n
ei ._
0
(D
.41
0'
_" F
0~
o
0 0
0O 0
0 oD
4a
d
o
d 0
o 4PHOTODYNAMIC DESTRUCTION OF HUMAN BLADDER CARCINOMA 241
*4
00
r .14
X X
0 O
a
X 0)
~0
(D _4
S .
_ -
4- 4
0 0
;; C
OQ-O
.00
0" 0 UJ. F. KELLY, M. E. SNELL AND M. C. BERENBAIUM
Implants of normal bladder tissue
(M, N, 0, P) grew well, the epithelium
generally containing moderate numbers
of mitotic figures and tending to form a
cyst (Fig. 3).
Localization of HpD
Twenty-four h after injecting HpD
the nodules were brightly fluorescent
and there was a halo of red fluorescence
in the surrounding skin and subcutaneous
tissues. The nodules of 2 of the 81
HpD treated mice (* in Fig. 1) were not
fluorescent and in one of these the
intestine fluoresced faintly. It is there-
fore likely that in these 2 the HpD had
inadvertently been injected into the gut,
from which it is poorly absorbed, rather
than into the peritoneum, and these
mice are accordingly excluded from further
consideration.
Nodules containing tumour could not
be distinguished by their fluorescence
from nodules containing normal bladder
or fibrous tissue only. The lymph nodes
were also fluorescent at that time, but no
other tissues.
In frozen sections, the connective
tissue capsule around the nodules was
intensely fluorescent and the tumour
fluoresced weakly but we could detect no
fluorescence in normal bladder tissues.
Thqre was no macroscopically visible
fluorescence in organs of mice which had
not been given HpD and sections of
these showed no red fluorescence in anv
tissue examined.
EJffect of HpD and light
(a) Macroscopic.-Only mice treated
with both HpD and light showed any
macroscopic reaction around their nodules.
Within 30 min of exposure to light the
tissues around the irradiated nodules
became oedematous and in several mice
the skin over the apex of the nodules
ulcerated within the next 24 h.
(b) Microscopic. Nodules treated
with HpD and light showed varying
degrees of damage, the extent of which
was graded as (a) total; (b) subtotal
(extending to 25% or more of the depth
of the nodule, but with deeper tissue
surviving (Fig. 2b); (c) superficial (ex-
tending to less than 25% of the depth
of the nodule; (d) irregular, (tissue sur-
viving superficially to damaged tissue);
(e) slight (scattered damage throughout
with most of the tissue surviving); and
(f) none (Fig. 3b).
At 48 h after irradiation, cells in
damaged tissue showed pyknosis and
karyorrhexis with eosinophilic cytoplasm,
or complete nuclear dissolution. Suffi-
cient histological pattern usually remained
to identify the damaged tissue but in a
few nodules necrosis was so marked that
the tissue was unidentifiable. Damaged
nodules sometimes showed interstitial
haemorrhage.
The skin over nodules treated with
HpD and light showed damage varying
from karyorrhexis of epidermal and hair
follicle cells to necrosis and ulceration.
The subcutaneous connective tissue was
oedematous, infiltrated with polymorphs
and sometimes haemorrhagic, and the
abdominal wall showed muscle fibre
necrosis.
The histological findings are sum-
marized in Fig. 1 and Table II. Two
TABLE II.- Effect of Combined Treatmient
with HpD and Light on Human Bladder
Carcinoma and Normal Tissue Growing
in Immunosuppressed Mice
Extent of
damage
Total
Subt Aal
Irregular
Slight
Superficial
None
Total
Tissue in implant
r _A_ ---A,
Normal Smooth
Carcinoma epithelium muscle
7 0 ()
15 1 1
3s O (1
2 0 1
() 0 5
5 14 13
32 15 20
conclusions are clear. First, nodules were
damaged only when they were exposed to
light in a mouse that had received HpD.
None of the 169 nodules that were un-
treated or treated with HpD or light
24-.PHOTODYNAMIC DESTRUCTION OF HUMAN BLADDER CARCINOMA
alone were damaged, but 48 of 78 nodules
that received both were damaged. Second,
there was a striking difference in suscepti-
bility to damage between carcinomatous
and normal bladder tissue. Of 32 tumour
implants treated with both HpD and
light, 25 showed total, subtotal or irregu-
larly distributed damage while 5 showed
none. In contrast, of 15 similarly treated
nodules of normal bladder epithelium 14
were uindamaged and only 1 showed
subtotal damage, and of 20 nodules
containing normal muscle one was sub-
totally damaged and the rest showed
either slight (1) or superficial damage (5)
or none at all (13).
DISCUSSION
Our findings show unequivocally that
human bladder carcinomata growing in
immunosuppressed mice are severely
damaged by combined treatment with
HpD and light whereas normal bladder
epithelium and muscle are comparatively
resistant to this treatment. It is possible
therefore that an effective treatment for
bladder carcinoma might be based on
this procedure. However, two problems
arise. First, with the technique we used,
light of sufficient intensity appeared to
penetrate only shallowly. The largest
nodules were 6 mm in diameter and
although tumour was destroyed at all
levels in most nodules, there were often
deeply situated remnants that may have
been viable. However, light was de-
livered through intact skin; this effectively
screens the shorter wavelengths (Bachem
and Reed, 1931) which are the principal
activators of HpD fluorescence. In fact,
we found it necessary to shave the mice
since otherwise exposuretolightforasmuch
as an hour caused no tumour damage.
The extent to which sufficient light would
penetrate a tumour not shielded by skin
is unknown but it may be no more than
5-10 mm, in which case this form of
treatment could not be used for deeply
infiltrating growths unless more powerful
cool light sources become available.
Second, it is possible that part of
the damage to these nodules is due to
damage to their vascular supply. We
observed that HpD fluorescence was
more intense in the connective tissue
immediately around the tumour nodules
than within the nodules themselves, and
we have seen this with implants of other
types of tumour. A fluorescent halo
has also been observed with transplanted
mouse tumours (Lipson et al., 1961) and
we have noted a similar distribution with
fluorescein. It is possible therefore that
the tumour damage observed by us and
others (Diamond et al., 1972; Dougherty,
1974) is due to damage to blood vessels
as they pass through the damaged sur-
rounding connective tissues. The ap-
parently selective production of damage
in bladder carcinoma compared with
normal bladder tissue might accordingly
be due not to inherent differences between
carcinomatous and normal tissues as they
exist in the patient, but to a greater
vulnerability to ischaemia of implanted
tumours compared with normal tissues.
This factor is unlikely to be of over-
riding importance for, inthe greatmajority
ofnodules that were not totally destroyed,
the distribution of damage was clearly
orientated towards the source of light
anid any surviving tissues were in the
deep, relatively shielded part of the
nodule. As fluorescence microscopy of
frozen sections showed a clear difference
in uptake of HpD between tumour and
normal bladder tissues, it is most likely
that their different susceptibilities to
photodynamic damage are due largely to
this factor.
However, there were occasional no-
dules in which damage was irregularly
distributed, and other factors may have
operated in these. It may be possible to
resolve this difficulty by experiments oIn
spontaneous, or primary, carcinogen-
induced tumours.
Studies in progress suggest that some
implants of bladder carcinoma are de-
stroyed by the treatment described, as
they show no histological evidence of
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surviving tumour tissue 2 months later.
Other nodules regrow, presumably those
in which deep tumour tissue has survived.
It is possible that these can be completely
destroyed by repeated treatments spaced
to allow removal of overlying necrotic
tumour.
Photodynamic therapy appears pro-
mising for human bladder carcinoma,
especially as we have found, by fluores-
cence cytoscopy and examination of sur-
gically removed material, that HpD
given to patients is selectively taken up
by bladder carcinomata (to be published).
However, because of the problem of light
transmission through tissue, it would
perhaps be most suitable for the treat-
ment of widespread superficial carcinoma
of the bladder, for which present methods
of intracavitary therapy are only partly
successful. It might also be used pro-
phylactically in the treatment ofrecurrent
cancer of the bladder, for HpD is taken
up selectively by early and in situ car-
cinoma in other sites (Gray et al., 1967;
Gregoire et al., 1968; Leonard and Beck,
1971).
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